Advertisements



iAnthus Reports Fiscal 2019 Financial Results and Provides Additional Business Updates

NEW YORK and TORONTO, July 31, 2020 /CNW/ - iA.....»»

Category: earningsSource: benzingaJul 31st, 2020

iAnthus Reports Fiscal 2019 Financial Results and Provides Additional Business Updates

NEW YORK and TORONTO, July 31, 2020 /CNW/ - iA.....»»

Category: earningsSource: benzingaJul 31st, 2020

Minerva Neurosciences Reports Fiscal 2019 Fourth Quarter and Year End Financial Results and Business Updates

Company confirms timing of expected top-line results from Phase 3 rol.....»»

Category: earningsSource: benzingaMar 9th, 2020

Myovant Sciences Provides Corporate Updates and Reports Financial Results for Fourth Fiscal Quarter and Full Fiscal Year Ended March 31, 2019

-Announced positive Phase 3 results from LIBERTY 1 study evaluating relugolix combination therapy in women with uterine fibroids- -Data from four additional Phase 3 clinical studies ex.....»»

Category: earningsSource: benzingaMay 24th, 2019

Quotient Limited Reports Senior Note Issuance and Warrant Cash Inflows and updates on MosaiQ Development and First Quarter Fiscal 2019 Financial Results

$48.8 million of proceeds from warrant exercises received through July 31 $36 million of additional senior notes issued and.....»»

Category: earningsSource: benzingaAug 6th, 2018

AMSC Reports Fourth Quarter and Full Fiscal Year 2019 Financial Results and Provides Business Outlook

AMSC Reports Fourth Quarter and Full Fiscal Year 2019 Financial Results and Provides Business Outlook.....»»

Category: earningsSource: benzingaJun 2nd, 2020

Updates - China Pharma Holdings, Inc. Reports Fiscal Year 2019 Financial Results

HA.....»»

Category: earningsSource: benzingaApr 14th, 2020

Windtree Therapeutics Reports Fourth Quarter 2019 Financial Results and Provides Key Business Updates

WARRINGTON, Pa., April 2, 2020 .....»»

Category: earningsSource: benzingaApr 2nd, 2020

Stealth BioTherapeutics Reports Fiscal Year 2019 Financial Results And Recent Business Highlights

BOSTON, April 1, 2020 /PRNewswire/ --├é┬áStealth BioTherapeutics Corp (NASDAQ:MITO), a clin.....»»

Category: earningsSource: benzingaApr 1st, 2020

Monopar Therapeutics Reports Fourth Quarter and Full-Year 2019 Financial Results and Business Updates

Initial public offering on Nasdaq Capital Market in December 2019 O.....»»

Category: earningsSource: benzingaMar 27th, 2020

Phathom Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Clinical Trial Status and Business Updates

Successfully Finished .....»»

Category: earningsSource: benzingaMar 19th, 2020

LogicBio Reports Full Year 2019 Financial Results and Provides Business Updates

CAMBRIDGE, Mass., March 16, 2020 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (NASDAQ:LOGC) (LogicBio or the Company), a genome editing company focused on developing medicines to durably treat rare diseases in pediatric patient.....»»

Category: earningsSource: benzingaMar 16th, 2020

Abeona Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Business Updates

Abeona Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Business Updates.....»»

Category: earningsSource: benzingaMar 16th, 2020

Galectin Therapeutics Reports Fiscal 2019 Financial Results and Provides Business Update

NORCROSS, Ga., March 1.....»»

Category: earningsSource: benzingaMar 16th, 2020

Precision BioSciences Reports Fourth Quarter and Fiscal Year 2019 Financial Results and Provides Business Update

-Presented initial clinical data for lead allogeneic CAR T program PBCAR0191 for the treatment of NHL and B-ALL- -Implemented amendment to PBCAR0191 Phase 1/2a trial focused on optimizing clinical activity,.....»»

Category: earningsSource: benzingaMar 10th, 2020

Select Energy Services Reports Fourth Quarter And Fiscal Year 2019 Financial Results And Operational Updates

Select Energy Services Reports Fourth Quarter And Fiscal Year 2019 Financial Results And Operational Updates.....»»

Category: earningsSource: benzingaFeb 24th, 2020

TLC Reports Fiscal Year End 2019 Financial Results and Provides Business Update

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwa.....»»

Category: earningsSource: benzingaFeb 11th, 2020

AMSC Reports Third Quarter Fiscal Year 2019 Financial Results and Provides Business Outlook

AMSC Reports Third Quarter Fiscal Year 2019 Financial Results and Provides Business Outlook.....»»

Category: earningsSource: benzingaFeb 5th, 2020

Outlook Therapeutics Provides Business Update and Reports Financial Results for Fiscal Year 2019

Topline results from the NORSE 1 study.....»»

Category: earningsSource: benzingaDec 19th, 2019

Anavex Life Sciences Reports Fiscal Year 2019 Financial Results And Provides Clinical Study Updates

Anavex Life Sciences Reports Fiscal Year 2019 Financial Results And Provides Clinical Study Updates.....»»

Category: earningsSource: benzingaDec 16th, 2019

Artelo Biosciences Reports Fourth Quarter and Fiscal Year 2019 Financial Results and Provides Business Update

LA JOLLA, Calif., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ:ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate the endocannabinoid system, today reported financial and .....»»

Category: earningsSource: benzingaNov 25th, 2019